MSB 4.00% $1.17 mesoblast limited

Ann: Mesoblast Phase 3 Chronic Heart Failure Results, page-379

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 4,888 Posts.
    lightbulb Created with Sketch. 892
    Sure but aren't there a long stream (many years) of these: "surprising, unexpected but potentially promising results". Take the motherhood crap away and isn't the following all that matters to investors?

    1. When is the earliest that CHF will start contributing to the bottom line?
    2. What is the projected earnings profile associated with CHF?
    3. How much more investment will be required to get them to that point?

    Because this company has shown over a long period that it has a great need for its shareholders Capital to pursue these "promising" results while richly rewarding its management with salary and options along the way.

    Today's announcement doesn't really do much to dispel that long term impression I've formed does it?
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.